In its latest bolt-on, Builders FirstSource announced Nov. 4 that it has acquired Lengefeld Lumber — a family-owned ...
Clear Street raised the firm’s price target on Beam Therapeutics (BEAM) to $37 from $34 and keeps a Buy rating on the shares following the Q3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback